Aldagen, a wholly owned subsidiary of Cytomedix, Inc., is a Durham, NC medical technology company, founded in March 2000. Aldagen focuses on the development of products utilizing their proprietary patented technologies for identification and isolation of adult stem cell populations for use in treatment of cardiovascular, peripheral vascular and other regenerative medicine applications.